| |
| |
|
| Insider
Information: |
Azab Mohammad |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
194,105 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$103,864 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
194,105 |
|
|
| Total
Value |
$103,864 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
| Percentage
Gain/Loss : |
 44.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novelion Therapeutics Inc |
NVLN |
Exec VP-R&D, CMO |
2005-05-24 |
1,200 |
|
0 |
Premium* |
|
|
Astex Pharmaceuticals Inc |
ASTX |
Chief Medical Officer |
2013-10-11 |
0 |
2013-10-11 |
0 |
Premium* |
|
|
Xenon Pharmaceuticals Inc. |
XENE |
|
2023-12-19 |
74,225 |
2015-01-08 |
0 |
Premium* |
|
|
Durect Corp |
DRRX |
Director |
2022-05-24 |
60,000 |
2022-05-16 |
0 |
Premium* |
|
|
Lisata Therapeutics Ord Shs |
LSTA |
Director |
2024-01-09 |
58,680 |
2022-09-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
26 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
26 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
